dpp-4 inhibitors vs. glp-1 agonist DPP4 vs Agonists | June 2021 | Clinical Corner dpp 4 inhibitor glp 1

Osteoarthritis (e.g., STEP 9)

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

A high concentration of KCl (60 mM) was administered to depolarize the cells, including the sympathetic nerve endings, and an increase in the NE concentration on the mucosal side was confirmed (Fig

By monitoring blood glucose profiles after administering a glucose solution to the mice, we performed glucose tolerance test (GTT)

Conclusion This systematic review highlights the significant impact of GLP-1-RA on hMSC differentiation and function, mediated through key pathways such as Wnt/-catenin, BMP/Smad, PI3K/Akt, and PKA

MR: Writing original draft, Methodology, Investigation, Supervision